Results 21 to 30 of about 1,465,354 (287)
International Journal of Preventive Medicine, 2023 Introduction: COVID-19 is a respiratory disease caused by infection with severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). Thrombotic complications appear to be of particular importance in patients with COVID-19.
Somayeh Haghighipour +5 more
doaj +1 more source
Prevalence of anticardiolipin antibody IgM and IgG in women with recurrent abortions in Kirkuk city
NTU Journal of Pure Sciences, 2023 Toxoplasma gondii, a parasite that can produce a wide range of clinical symptoms in humans, is the source of the zoonotic infection known as Toxoplasmosis.
Muna Aziz, Abeer Ali, Mohammed Hameed
doaj +1 more source
Antiphospholipid Antibodies in Patients with Type 2 Diabetes Mellitus [PDF]
Annals of the College of Medicine Mosul, 2020 Patients with diabetes mellitus type 2 have a greater risk of accelerated atherosclerosis. Antiphospholipid antibodies(aPL)are associated with greater risk for thrombosis.
Nada Hasso, Ahmed Hussain, Ali Fatheel
doaj +1 more source
Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification [PDF]
, 2019 Background: Anticardiolipin (aCL) and anti-beta 2 glycoprotein I (a beta 2GPI) immunoglobulin (Ig) G/IgM antibodies are 2 of the 3 laboratory criteria for classification of antiphospholipid syndrome (APS).
de Laat, Bas +4 more
core +3 more sources
SARS-CoV-2 and Anti-Cardiolipin Antibodies
Clinical Medicine Insights: Case Reports, 2020 The current COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to distinct diagnostic and management challenges for front-line healthcare workers. The risk of excessive coagulation activation leading to a
Mazen Jizzini, Mohsin Shah, Kehua Zhou
doaj +1 more source
Anticardiolipin antibodies in pathogenesis of infertility [PDF]
Vojnosanitetski Pregled, 2010 Background/Aim. Antiphospholipid syndrome (APS) is an autoimmune disorder clinically characterized by arterial or venous thrombosis and/or specific obstetric complications and presence of antiphospholipid antibodies (aPL) in the serum.
Lončar Dragan
doaj +1 more source
Do we need broad immunological work-up in all patients with CIS? [PDF]
, 2012 BACKGROUND: The aim of this study was to determine the prevalence of altered immunological tests and their clinical significance in patients with clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS). ----- PATIENTS AND METHODS:
Adamec, Ivan +6 more
core +1 more source
Вестник трансплантологии и искусственных органов, 2010 One of the most essential autoimmunity risk factors for development of CAD are increasing level of anticardiolipin antibodies and homocystein. This report presents retrospective analyses of 39 heart transplant recipients with maximal follow up over 16 ...
T. A. Khalilulin +6 more
doaj +1 more source
Hepatic venous outflow block in a young patient with Systemic Lupus Erythematosus [PDF]
Journal of Analytical Research in Clinical Medicine, 2015 Introduction: Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a 3 years survival rate of 50%. Several conditions have been implicated as a cause of Budd-Chiari syndrome, including myeloproliferative disorders ...
Ali Ghavidel
doaj +1 more source